Effects of single doses of rabeprazole 20 mg and esomeprazole 40 mg on 24-h intragastric pH in healthy subjects

被引:14
|
作者
Warrington, Steve
Baisley, Kathy
Dunn, Kate
Boyce, Malcolm
Morocutti, Anna
机构
[1] Cent Middlesex Hosp, London NW10 7NS, England
[2] Eisai Ltd, London W6 8EE, England
基金
英国医学研究理事会;
关键词
esomeprazole; intragastric acidity; on-demand therapy; proton pump inhibitors; rabeprazole;
D O I
10.1007/s00228-006-0148-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: To compare antisecretory effects of single doses of rabeprazole and esomeprazole. Methods: Open, randomised, 2-way crossover, clinical pharmacology study. 24 healthy subjects (10 men; mean age 26.2 y) received a single dose of rabeprazole 20 mg or esomeprazole 40 mg, with a 14-day 'washout'. Intragastric pH was recorded continuously from 24 h before to 24 h after dosing.Results: Mean intragastric pH was higher after esomeprazole than rabeprazole during 0-5 h after dosing (P=0.0001); the reverse was true from 14-24 h (P=0.0002). Mean % time pH > 3 and > 4 was greater after esomeprazole than rabeprazole during 0-14 h (P=0.041 and 0.044), but the reverse was true during 14-24 h (P=0.0005 and 0.001). In the 0-24 h interval as a whole, there was no difference between treatments in mean pH or % time pH > 3 or > 4. Conclusion: Single-dose rabeprazole 20 mg was as effective as esomeprazole 40 mg in increasing intragastric pH and maintaining pH > 3 and > 4, despite the 2-fold difference in dose.
引用
收藏
页码:685 / 691
页数:7
相关论文
共 50 条
  • [1] Effects of single doses of rabeprazole 20 mg and esomeprazole 40 mg on 24-h intragastric pH in healthy subjects
    Steve Warrington
    Kathy Baisley
    Kate Dunn
    Malcolm Boyce
    Anna Morocutti
    [J]. European Journal of Clinical Pharmacology, 2006, 62 : 685 - 691
  • [2] Effects of rabeprazole, 20 mg, or esomeprazole, 20 mg, on 24-h intragastric pH and serum gastrin in healthy subjects
    Warrington, S
    Baisley, K
    Boyce, M
    Tejura, B
    Morocutti, A
    Miller, N
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (07) : 1301 - 1307
  • [3] Effects of rabeprazole, 20 mg, or esomeprazole, 20 mg, on 24-h intragastric pH in H. pylori positive PPI extensive metabolizers
    Isakov, VA
    Morozov, SV
    Tsodikova, OM
    Guschin, AE
    [J]. GASTROENTEROLOGY, 2004, 126 (04) : A340 - A340
  • [4] Rabeprazole 20 mg compared with esomeprazole 40 mg in the control of intragastric pH in healthy volunteers
    Baisley, K
    Warrington, S
    Tejura, B
    Morocutti, A
    Miller, N
    [J]. GUT, 2002, 50 : A63 - A63
  • [5] Rabeprazole 20 mg compared with esomeprazole 40 mg in the control of intragastric pH in healthy volunteers
    Baisley, K
    Warrington, S
    Tejura, B
    Morocutti, A
    Miller, N
    [J]. GASTROENTEROLOGY, 2002, 122 (04) : A199 - A199
  • [6] Effect of intravenous esomeprazole 40 mg and pantoprazole 40 mg on intragastric pH in healthy subjects
    Piccoli, Franziska
    Ory, Gaeelle
    Hadengue, Antoine
    Beglinger, Christoph
    Degen, Lukas
    [J]. ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2007, 57 (10): : 654 - 658
  • [7] Comparison of esomeprazole (20, 40, 80 mg) versus lansoprazole (15, 30 and mg) on intragastric pH in healthy subjects
    Wilder-Smith, C
    Lind, T
    Lundin, C
    Nilsson-Pieschl, C
    Rohss, KM
    Naucler, E
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : A444 - A444
  • [8] Early effects of tenatoprazole 40 mg and esomeprazole 40 mg on intragastric pH in Caucasian healthy volunteers
    Galmiche, JP
    des Varannes, SB
    Sacher-Huvelin, S
    Vavasseur, F
    Taccoen, A
    Fiorentini, P
    Homerin, M
    [J]. GASTROENTEROLOGY, 2004, 126 (04) : A334 - A334
  • [9] Comparison of the effects of esomeprazole 40 mg, rabeprazole 20 mg, lansoprazole 30 mg, and pantoprazole 40 mg on intragastric pH in extensive metabolizer patients with gastroesophageal reflux disease
    Celebi, Altay
    Aydin, Dincer
    Kocaman, Orhan
    Konduk, Bugra Tolga
    Senturk, Omer
    Hulagu, Sadetin
    [J]. TURKISH JOURNAL OF GASTROENTEROLOGY, 2016, 27 (05): : 408 - 414
  • [10] Esomeprazole 40 mg provides improved intragastric acid control as compared with lansoprazole 30 mg and rabeprazole 20 mg in healthy volunteers
    Wilder-Smith, CH
    Röhss, K
    Nilsson-Pieschl, C
    Junghard, O
    Nyman, L
    [J]. DIGESTION, 2003, 68 (04) : 184 - 188